PT  - JOURNAL ARTICLE
AU  - Helwick, Caroline
ED  - Tardif, Jean-Claude
TI  - Succinobucol Treatment Leads to Mixed Signals
DP  - 2007 Jun 01
TA  - MD Conference Express
PG  - 22--23
VI  - 7
IP  - 1
4099  - http://mdc.sagepub.com/content/7/1/22.short
4100  - http://mdc.sagepub.com/content/7/1/22.full
AB  - Succinobucol (AGI-1067) is a novel compound believed to reduce inflammation in blood vessel walls. This article gives an overview of the findings from the Phase 3 randomized, double-blind Aggressive Reduction of Inflammation Stops Events [ARISE] study.